CG Diagnostics Limited 13850300 false 2023-02-01 2024-01-31 2024-01-31 The principal activity of the company is to provide medical services. Digita Accounts Production Advanced 6.30.9574.0 true 13850300 2023-02-01 2024-01-31 13850300 2024-01-31 13850300 core:RetainedEarningsAccumulatedLosses 2024-01-31 13850300 core:ShareCapital 2024-01-31 13850300 core:CurrentFinancialInstruments 2024-01-31 13850300 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 13850300 bus:SmallEntities 2023-02-01 2024-01-31 13850300 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 13850300 bus:FilletedAccounts 2023-02-01 2024-01-31 13850300 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 13850300 bus:RegisteredOffice 2023-02-01 2024-01-31 13850300 bus:Director1 2023-02-01 2024-01-31 13850300 bus:Director2 2023-02-01 2024-01-31 13850300 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13850300 countries:EnglandWales 2023-02-01 2024-01-31 13850300 2022-01-14 2023-01-31 13850300 2023-01-31 13850300 core:RetainedEarningsAccumulatedLosses 2023-01-31 13850300 core:ShareCapital 2023-01-31 13850300 core:CurrentFinancialInstruments 2023-01-31 13850300 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 iso4217:GBP xbrli:pure

Registration number: 13850300

CG Diagnostics Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 January 2024

Pages for filing with Registrar

 

CG Diagnostics Limited

Contents


 

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 6

 

CG Diagnostics Limited

Company Information


 

Directors

Dr C M Gutteridge

Dr G P Smith

Registered office

19 Whiteford Road
Plymouth
Devon
PL3 5LU

 

CG Diagnostics Limited

(Registration number: 13850300)
Balance Sheet as at 31 January 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

461

863

Cash at bank and in hand

 

81,390

42,544

 

81,851

43,407

Creditors: Amounts falling due within one year

5

(13,608)

(12,727)

Net assets

 

68,243

30,680

Capital and reserves

 

Called up share capital

10

10

Retained earnings

68,233

30,670

Shareholders' funds

 

68,243

30,680

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 29 August 2024 and signed on its behalf by:
 

.........................................
Dr C M Gutteridge
Director

 

CG Diagnostics Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
19 Whiteford Road
Plymouth
Devon
PL3 5LU
England

These financial statements were authorised for issue by the Board on 29 August 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in Sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

CG Diagnostics Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024 (continued)

2

Accounting policies (continued)

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

CG Diagnostics Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024 (continued)

2

Accounting policies (continued)

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments.

Financial instruments

Classification
The Company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the Company’s statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and liability simultaneously.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. As equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4

Debtors

Current

2024
£

2023
£

Prepayments

461

863

 

461

863

 

CG Diagnostics Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024 (continued)

5

Creditors

2024
£

2023
£

Due within one year

Taxation and social security

8,812

7,617

Accruals and deferred income

300

300

Other creditors

4,496

4,810

13,608

12,727